353 related articles for article (PubMed ID: 30632816)
1. Novel Immunotherapeutics for Treatment of Glioblastoma: The Last Decade of Research.
Khansur E; Shah AH; Lacy K; Komotar RJ
Cancer Invest; 2019; 37(1):1-7. PubMed ID: 30632816
[TBL] [Abstract][Full Text] [Related]
2. Novel Immunotherapeutics for the Treatment of Glioblastoma: The Last Decade of Research.
Khansur EM; Shah AH; Lacy K; Kuchakulla M; Komotar RJ
Cureus; 2018 Jan; 10(1):e2130. PubMed ID: 29692957
[TBL] [Abstract][Full Text] [Related]
3. Clinical Trials Investigating Immune Checkpoint Blockade in Glioblastoma.
Maxwell R; Jackson CM; Lim M
Curr Treat Options Oncol; 2017 Aug; 18(8):51. PubMed ID: 28785997
[TBL] [Abstract][Full Text] [Related]
4. Current Immunotherapies for Glioblastoma Multiforme.
Huang B; Li X; Li Y; Zhang J; Zong Z; Zhang H
Front Immunol; 2020; 11():603911. PubMed ID: 33767690
[TBL] [Abstract][Full Text] [Related]
5. Advances in Immunotherapy for Glioblastoma Multiforme.
Huang B; Zhang H; Gu L; Ye B; Jian Z; Stary C; Xiong X
J Immunol Res; 2017; 2017():3597613. PubMed ID: 28299344
[TBL] [Abstract][Full Text] [Related]
6. Vaccine-Based Immunotherapeutics for the Treatment of Glioblastoma: Advances, Challenges, and Future Perspectives.
Cuoco JA; Benko MJ; Busch CM; Rogers CM; Prickett JT; Marvin EA
World Neurosurg; 2018 Dec; 120():302-315. PubMed ID: 30196171
[TBL] [Abstract][Full Text] [Related]
7. Emerging immunotherapies for glioblastoma.
Desai R; Suryadevara CM; Batich KA; Farber SH; Sanchez-Perez L; Sampson JH
Expert Opin Emerg Drugs; 2016 Jun; 21(2):133-45. PubMed ID: 27223671
[TBL] [Abstract][Full Text] [Related]
8. Current Advances in Immunotherapy for Glioblastoma.
Mende AL; Schulte JD; Okada H; Clarke JL
Curr Oncol Rep; 2021 Jan; 23(2):21. PubMed ID: 33496872
[TBL] [Abstract][Full Text] [Related]
9. Heat shock proteins in glioblastomas.
Yang I; Fang S; Parsa AT
Neurosurg Clin N Am; 2010 Jan; 21(1):111-23. PubMed ID: 19944971
[TBL] [Abstract][Full Text] [Related]
10. [Immunotherapy in brain tumors].
De Carli E; Delion M; Rousseau A
Ann Pathol; 2017 Feb; 37(1):117-126. PubMed ID: 28111040
[TBL] [Abstract][Full Text] [Related]
11. Immune checkpoint inhibition and its relationship with hypermutation phenoytype as a potential treatment for Glioblastoma.
Sinnadurai M; McDonald KL
J Neurooncol; 2017 May; 132(3):359-372. PubMed ID: 28293764
[TBL] [Abstract][Full Text] [Related]
12. The need for paradigm shift: prognostic significance and implications of standard therapy-related systemic immunosuppression in glioblastoma for immunotherapy and oncolytic virotherapy.
Stepanenko AA; Sosnovtseva AO; Valikhov MP; Chernysheva AA; Abramova OV; Naumenko VA; Chekhonin VP
Front Immunol; 2024; 15():1326757. PubMed ID: 38390330
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell immunotherapy for malignant gliomas.
Luptrawan A; Liu G; Yu JS
Rev Recent Clin Trials; 2008 Jan; 3(1):10-21. PubMed ID: 18474011
[TBL] [Abstract][Full Text] [Related]
14. Heat shock protein vaccines against glioblastoma: from bench to bedside.
Ampie L; Choy W; Lamano JB; Fakurnejad S; Bloch O; Parsa AT
J Neurooncol; 2015 Jul; 123(3):441-8. PubMed ID: 26093618
[TBL] [Abstract][Full Text] [Related]
15. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.
Agosti E; Zeppieri M; De Maria L; Tedeschi C; Fontanella MM; Panciani PP; Ius T
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894718
[TBL] [Abstract][Full Text] [Related]
16. How We Treat Recurrent Glioblastoma Today and Current Evidence.
Chaul-Barbosa C; Marques DF
Curr Oncol Rep; 2019 Oct; 21(10):94. PubMed ID: 31606796
[TBL] [Abstract][Full Text] [Related]
17. Prospects of biological and synthetic pharmacotherapies for glioblastoma.
Altshuler DB; Kadiyala P; Nuñez FJ; Nuñez FM; Carney S; Alghamri MS; Garcia-Fabiani MB; Asad AS; Nicola Candia AJ; Candolfi M; Lahann J; Moon JJ; Schwendeman A; Lowenstein PR; Castro MG
Expert Opin Biol Ther; 2020 Mar; 20(3):305-317. PubMed ID: 31959027
[No Abstract] [Full Text] [Related]
18. Immunotherapy approaches in the treatment of malignant brain tumors.
Dunn-Pirio AM; Vlahovic G
Cancer; 2017 Mar; 123(5):734-750. PubMed ID: 27875627
[TBL] [Abstract][Full Text] [Related]
19. Novel Clinical Trials and Approaches in the Management of Glioblastoma.
Valerius AR; Webb LM; Sener U
Curr Oncol Rep; 2024 May; 26(5):439-465. PubMed ID: 38546941
[TBL] [Abstract][Full Text] [Related]
20. Current challenges in designing GBM trials for immunotherapy.
Weathers SP; Gilbert MR
J Neurooncol; 2015 Jul; 123(3):331-7. PubMed ID: 25577401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
